Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.

Saved in:
Bibliographic Details
Title: Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.
Authors: de Azambuja, E.1, Zardavas, D.1, Lemort, M.1, Rossari, J.2, Moulin, C.3, Buttice, A.1, D'Hondt, V.1, Lebrun, F.1, Lalami, Y.1, Cardoso, F.4, Sotiriou, C.1, Gil, T.1, Devriendt, D.1, Paesmans, M.1, Piccart-Gebhart, M.1, Awada, A.1
Source: Annals of Oncology. Dec2013, Vol. 24 Issue 12, p2985-2989. 5p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdt359